25 Jul 2008
CHEMTURA TO SHOWCASE GREENER PRODUCTS THAT ENABLE HIGHER YIELD, AVOIDING UNWANTED BYPRODUCTS
Special to CPHi
Chemtura Corporation (NYSE:CEM ) supplies tailor-made organometallic and bromine specialties for the production of a broad range of active pharmaceuticals (APIs), including treatments for hypertension, HIV, Alzheimer’s disease and hormonal conditions, as well as enabling the creation of high-potency drugs.
Chemtura experts on bromide and organometallics are available to discuss customer requirements at Booth 50C54, Hall 50.
For discussion:
Reader enquiries
Chemtura Corporation199 Benson Road
Middlebury, CT 06749
United States
+1 203 573 2220
www.chemtura.com
Notes for editors
About Chemtura Corporation
Chemtura Corporation (NYSE:CEM) was created in 2005 by combining the resources of Crompton and Great Lakes Chemical Corporations. With 2007 sales of $3.7 billion, Chemtura is a global manufacturer and marketer of specialty chemicals, crop protection and pool, spa and home care products.
Please visit www.chemtura.com .